GE Helathcare, together with OrbiMed Israel, announced a $20 million investment in Ornim, a developer of the CerOx monitor that non-invasively monitors blood flow and oxygen saturation in brain and muscle tissue. The investment was made as part of a financing round led by OrbiMed, also including Agate Medical Investment Fund. The financing will be used for further development, clinical studies, international marketing and commercialization of Ornim’s CerOx monitor. Ornim Medical, based in Lod, Israel, was founded in 2004.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments